Autism Speaks reported initial results for the first industry-sponsored Autism Clinical Trials Network study, the Study of Fluoxetine in Autism which showed that fluoxetine was not effective for reducing repetitive behaviors in children and adolescents with autistic disorder as compared to placebo. The study of 158 patients (ages 5 — 17) was carried out in 19 CTN sites.
Read the latest issue!ICare4Autism Magazine Fall Issue
Click to launch the full edition in a new window
More Autism News